chr11-2572870-G-A

Variant summary

Our verdict is Pathogenic.
>+14 Pathogenic
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 17 classification points (ACMG Germline Pathogenicity v2019). PS3PM1PM2_SupportingPM5PP3_StrongPP5_Strong

The NM_000218.3(KCNQ1):c.805G>A (p.Gly269Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a cumulative frequency of 0.0000198 (AC=29) in the gnomAD database across 1,461,454 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.0000653. Note: a gnomAD entry for this variant shows a statistical allele-bias signature, consistent with mosaic/somatic contamination (e.g. age-related clonal hematopoiesis) rather than true inherited population frequency — this frequency should not be read as evidence of a common, benign germline variant. In-silico predictor (REVEL) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. The affected nucleotide is highly conserved across species (PhyloP 100-way vertebrate score: 9.42). Variant has been reported in ClinVar as Pathogenic/Likely Pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV005399103: "This variant has moderate functional evidence supporting abnormal protein function. In vitro studies show that this variant has abnormal delayed rectifier potassium current, defects in subcellular localisation, reduced stability, and a dominant negative effect over wild type (PMID:20044973, 24184248)."" and additional evidence is available in ClinVar. A different missense at the same amino acid position has been reported as Pathogenic/Likely Pathogenic in ClinVar: p.G269V: Pathogenic (ClinVar VariationId 200899, 1 star) This exact variant is curated in the UniProt human variants database as Pathogenic, associated with Long qt syndrome 1 (lqt1).

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000020 ( 0 hom. )

Consequence

KCNQ1
NM_000218.3 missense

Scores

13
4
3

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:14O:1

Conservation

PhyloP100: 9.42

Publications

1 publications found
Variant links:
Genes affected
KCNQ1 (HGNC:6294): (potassium voltage-gated channel subfamily Q member 1) This gene encodes a voltage-gated potassium channel required for repolarization phase of the cardiac action potential. This protein can form heteromultimers with two other potassium channel proteins, KCNE1 and KCNE3. Mutations in this gene are associated with hereditary long QT syndrome 1 (also known as Romano-Ward syndrome), Jervell and Lange-Nielsen syndrome, and familial atrial fibrillation. This gene exhibits tissue-specific imprinting, with preferential expression from the maternal allele in some tissues, and biallelic expression in others. This gene is located in a region of chromosome 11 amongst other imprinted genes that are associated with Beckwith-Wiedemann syndrome (BWS), and itself has been shown to be disrupted by chromosomal rearrangements in patients with BWS. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Aug 2011]
KCNQ1 Gene-Disease associations (from GenCC):
  • long QT syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • Jervell and Lange-Nielsen syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Jervell and Lange-Nielsen syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • long QT syndrome 1
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • atrial fibrillation, familial, 3
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • short QT syndrome
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • short QT syndrome type 2
    Inheritance: AD Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • familial atrial fibrillation
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Jervell and Lange-Nielsen syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • familial hypertrophic cardiomyopathy
    Inheritance: AD Classification: NO_KNOWN Submitted by: G2P
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000218.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript:

Our verdict: Pathogenic. The variant received 17 points.

PS3Functional studies show damaging effect
Well-established functional study supports damaging effect (PS3); SCV005399103: "This variant has moderate functional evidence supporting abnormal protein function. In vitro studies show that this variant has abnormal delayed rectifier potassium current, defects in subcellular localisation, reduced stability, and a dominant negative effect over wild type (PMID: 20044973, 24184248)."; SCV005440608: "Well-established in vitro or in vivo functional studies supportive of a damaging effect on the gene or gene product."; SCV000234421: Published functional studies demonstrate a damaging effect as this variant may cause abnormal assembly and stability of the potassium channel and exert moderate dominant-negative suppression of the potassium channel (Verma et al., 2009; Wu et al., 2014; Wang et al., 2014); SCV000543295: Experimental studies have shown that this missense change affects KCNQ1 function (PMID: 20044973, 24184248).; SCV005426308: A functional study has shown that this variant leads to a modest reduction in potassium channel current under control conditions and results in a completely blunted channel response to PKA stimulation (PMID: 24184248).; SCV001160534: "functional studies demonstrate that the p.Gly269Ser variant causes a reduction in potassium ion current and protein stability (Wu 2014 and Verma 2010)."; SCV002675873: "In multiple assays testing KCNQ1 function, this variant showed functionally abnormal results (Murray A et al. J. Med. Genet., 2002 Sep;39:681-5; Wu J et al. J. Am. Coll. Cardiol., 2014 Mar;63:819-27)."; SCV006064784: A functional study has shown that this variant leads to a modest reduction in potassium channel current under control conditions and results in a completely blunted channel response to PKA stimulation (PMID: 24184248).
PM1Mutational hot spot or critical domain
Missense neighbourhood hotspot (≥2 P/LP within ±8 AA, OR ≥ 5 vs. background) — PM1; In-domain: 0 pathogenic, 0 benign rare missense variants.; ±8 AA neighbourhood: 23 pathogenic, 1 benign (OR vs. background: 78.3).
PM2Absent/extremely low in population databases
Rare in gnomAD for AD/XL gene (popmax AF below threshold) — PM2 Supporting; GnomAD popmax AF = 0.0000653 — borderline rare for AD+AR gene (base 0.0001, raised to 0.00022 by highest known P/LP ClinVar AF 0.00022) — PM2 supporting.
PM5Novel missense at known pathogenic residue
Different pathogenic missense at same AA residue in ClinVar (PM5); ClinVar contains a germline Pathogenic/Likely Pathogenic entry at the same amino acid position with a different amino acid change: p.G269V: Pathogenic (ClinVar VariationId 200899, 1 star)
PP3Computational evidence supports damaging effect
Germline meta computational scorer (REVEL/MetaRNN/BayesDel) predicts damaging effect — strong evidence (PP3); Splicing verdict: not pathogenic.; Germline computational verdict: pathogenic (Strong).
PP5Reputable source reports pathogenic
ClinVar 2-star pathogenic — strong (PP5); ClinVar submissions overwhelmingly pathogenic (≥10 total, ≥80% P/LP, <10% B/LB) — strong (PP5, count-based); ClinVar germline classification: Pathogenic/Likely Pathogenic, 2 star(s). ClinVar submissions strongly and reliably favor pathogenicity (14/14 total P/LP).

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_000218.3. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

KCNQ1 NM_000218.3
MANE Select
HGVSc / HGVSpc.805G>Ap.Gly269Ser
Exon rankExon 6 of 16
missense
Prot: NP_000209.2
KCNQ1 NM_001406836.1
HGVSc / HGVSpc.805G>Ap.Gly269Ser
Exon rankExon 6 of 15
missense
Prot: NP_001393765.1
KCNQ1 NM_001406837.1
HGVSc / HGVSpc.535G>Ap.Gly179Ser
Exon rankExon 7 of 17
missense
Prot: NP_001393766.1

Ensembl Transcripts

KCNQ1 ENST00000155840.12
TSL:1MANE Select
HGVSc / HGVSpc.805G>Ap.Gly269Ser
Exon rankExon 6 of 16
missense
Prot: ENSP00000155840.2UniProt: P51787-1
KCNQ1 ENST00000335475.6
TSL:1
HGVSc / HGVSpc.424G>Ap.Gly142Ser
Exon rankExon 6 of 16
missense
Prot: ENSP00000334497.5UniProt: P51787-2
KCNQ1 ENST00000910997.1
HGVSc / HGVSpc.802G>Ap.Gly268Ser
Exon rankExon 6 of 16
missense
Prot: ENSP00000581056.1UniProt: A0ACI8SIJ2

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 6 sources
GnomAD3 genomes
AF: 0.00000657
AC:1
Hom:0
AN:152238
Cov:33
GnomAD2 exomes
AF: 0.00000399
AC:1
AN:250528
GnomAD4 exome
AF: 0.0000198
AC:29
Hom:0
AN:1461454
Cov:32
GnomAD4 genome
Warning
AF: 0.00000656
AC:1
Hom:0
AN:152356
Cov:33
TOPMed (Bravo)
AF: 0.00000378
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.0000185
AC:4
Hom:0
AN:216362
Local & regional cohorts 2 sources
ABraOM SABE-WGS-1171
AF: 0.000427
AC:1
Hom:0
AN:2342
ToMMo 61KJPN (+60KJPN MNV)
AF: 0.0000160
AC:2
Hom:0
AN:122504
Showing 8 sources

Case/control cohorts

CohortCasesControls
AFACANAFACAN
BipEx
(Bipolar disorder (including schizoaffective))
0.0000352 128420 0.0000347 128844
Epi25
(Epilepsy)
0.00 041958 0.0000150 166888
SCHEMA
(Schizophrenia)
0.00000970 1103044 0.0000163 3184104
Showing 3 cohortsAllele count / allele number. AF is computed from the counts for ASC (not provided by the source).

ClinVar

ClinVar submissions
Significance:Pathogenic
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
4
-
-
Long QT syndrome (4)
4
-
-
Long QT syndrome 1 (4)
2
-
-
Cardiovascular phenotype (2)
1
-
-
Beckwith-Wiedemann syndrome;C1837014:Atrial fibrillation, familial, 3;C1865019:Short QT syndrome type 2;C4551509:Jervell and Lange-Nielsen syndrome 1;C4551647:Long QT syndrome 1 (1)
1
-
-
Cardiac arrhythmia (1)
1
-
-
not provided (1)
1
-
-
not specified (1)
-
-
-
Congenital long QT syndrome (1)

Computational Scores

AlphaGenome AVI
Pathogenic29
AlphaMissense
Pathogenic0.93
BayesDel_addAF
Pathogenic0.49D
BayesDel_noAF
Pathogenic0.54
CADD
Pathogenic33
CardioboostArm
Pathogenic1.0
DANN
Uncertain1.0
DEOGEN2
Pathogenic0.98D
Eigen
Uncertain0.49
Eigen_PC
Uncertain0.43
FATHMM_MKL
Uncertain0.97D
FuncVEP CTI
Pathogenic1.0
GPN-Star LLR
N/A-9.8
GPN-Star score
N/A9.8
LIST_S2
Pathogenic0.99D
M_CAP
Pathogenic0.91D
MetaRNN
Pathogenic0.97D
MetaSVM
Pathogenic1.1D
Mutation Taster
N/A0/100disease causing (ClinVar)
MutationAssessor
Benign1.4L
PhyloP100
Pathogenic9.4
popEVE
Benign-3.5
PrimateAI
Pathogenic0.85D
PROVEAN
Pathogenic-5.9D
REVEL
Pathogenic0.93
Sift
Benign0.070T
Sift4G
Benign0.075T
Varity_R
N/A0.97
VESM-3B
Benign-11
Showing 29 of 29 scores

Splicing Scores

Pangolin (max)
Benign0.030
SpliceAI score (max)
Benign0.070
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.